Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Stereotactic Body Radiation Therapy for Unresectable Hepatocellular Carcinoma

NCT00914355 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00914355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Stereotactic Body Radiation Therapy for Unresectable Hepatocellular Carcinoma
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
December 8, 2020
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma